Closing Bell Overtime: Stocks Keep Rallying, Biotech Buyout Boom & Under the Radar Housing Play 12/26/23
Stocks surging again as the major averages try to extend an 8-week win streak. Long-time bull Tom Lee says the market can keep rallying in the new year – and reveals which group he thinks can soar 50%. Another day, another buyout in the biotech industry. This time it's two deals. Astrazeneca acquiring Gracell Biotechnoligies for $1.2B and Bristol Myers buying Rayzebio for $4.1b and comes just days after Bristol announced a $14b deal for Karuna Therapeutics. Wedbush Biotech analyst Laura Chico says the M&A action should continue next year and names her top picks in the space. The Mastercard…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.